{
    "fund_name": "First Trust NYSE Arca Biotechnology UCITS ETF",
    "type": "ETF",
    "ucits": true,
    "replication_method": "physical",
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "complex_factors": [],
    "classification": "non-complex",
    "supporting_data": "The ETF uses physical replication to track the NYSE Arca Biotechnology Index, with no mention of synthetic replication, swaps, or derivatives. The fund invests directly in equity securities of biotechnology companies, with no leverage or inverse exposure. The risk profile (SRRI 6) is high due to the sector's volatility, but this does not indicate complexity under MiFID II. The fund is UCITS-compliant, further supporting its non-complex classification.",
    "confidence": 95
}